Phibro Animal Health Corporation Market Cap ($820.58 Million)
Market Cap & Net Worth: Phibro Animal Health Corporation (PAHC)
Phibro Animal Health Corporation market cap. Phibro Animal Health Corporation (NASDAQ:PAHC) has a market capitalization of $820.58 Million ($820.58 Million) as of November 1, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #9393 globally and #2650 in its home market, demonstrating a -2.34% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Phibro Animal Health Corporation's stock price $38.88 by its total outstanding shares 21105569 (21.11 Million). Also see PAHC cash generation efficiency for how efficiently the company converts equity into cash flow.
Phibro Animal Health Corporation Market Cap History (2015–2026)
Phibro Animal Health Corporation market cap history from 2015 to 2026. Data shows growth from $523.85 Million to $820.58 Million (3.26% CAGR). Check today's stock price for Phibro Animal Health Corporation for real-time trading data and today's change.
Index Memberships
Phibro Animal Health Corporation is a constituent of 4 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.62 Trillion | 0.03% | #273 of 976 |
|
NASDAQ Composite
IXIC
|
$40.09 Trillion | 0.00% | #1008 of 3165 |
|
NASDAQ Biotechnology
NBI
|
$1.84 Trillion | 0.04% | #160 of 263 |
|
S&P Small-Cap 600 Index
SML
|
$1.56 Trillion | 0.03% | #496 of 602 |
Weight: Phibro Animal Health Corporation's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Phibro Animal Health Corporation Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Phibro Animal Health Corporation's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Phibro Animal Health Corporation annual equity growth to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.54x
Phibro Animal Health Corporation's market cap is 0.54 times its annual revenue
Latest Price to Earnings (P/E) Ratio
8.23x
Phibro Animal Health Corporation's market cap is 8.23 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $599.32 Million | $764.30 Million | $64.60 Million | 0.78x | 9.28x |
| 2018 | $581.33 Million | $820.00 Million | $64.90 Million | 0.71x | 8.96x |
| 2019 | $457.48 Million | $828.00 Million | $54.70 Million | 0.55x | 8.36x |
| 2020 | $365.59 Million | $800.35 Million | $33.55 Million | 0.46x | 10.90x |
| 2021 | $392.19 Million | $833.35 Million | $54.38 Million | 0.47x | 7.21x |
| 2022 | $265.42 Million | $942.26 Million | $49.17 Million | 0.28x | 5.40x |
| 2023 | $237.92 Million | $977.89 Million | $32.61 Million | 0.24x | 7.30x |
| 2024 | $443.22 Million | $1.02 Billion | $2.42 Million | 0.44x | 183.45x |
| 2025 | $788.50 Million | $1.30 Billion | $48.26 Million | 0.61x | 16.34x |
| 2026 | $820.58 Million | $1.52 Billion | $99.72 Million | 0.54x | 8.23x |
Competitor Companies of PAHC by Market Capitalization
Companies near Phibro Animal Health Corporation in the global market cap rankings as of November 1, 2026. Also see Phibro Animal Health Corporation (PAHC) total assets for a full breakdown of the balance sheet.
Key companies related to Phibro Animal Health Corporation by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #511 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #535 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #593 globally with a market cap of $45.23 Billion USD ( CN¥309.13 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #619 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #511 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #535 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $46.62 |
| #593 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.23 Billion | CN¥48.46 |
| #619 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.30 |
Market Capitalization of Phibro Animal Health Corporation (2015–2026)
Market capitalization of Phibro Animal Health Corporation from 2015 to today. Between 2015 and today, Phibro Animal Health Corporation's market cap moved from $523.85 Million to $ 820.58 Million, with a yearly change of 3.26%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $820.58 Million | +4.07% |
| 2025 | $788.50 Million | +77.90% |
| 2024 | $443.22 Million | +86.29% |
| 2023 | $237.92 Million | -10.36% |
| 2022 | $265.42 Million | -32.32% |
| 2021 | $392.19 Million | +7.28% |
| 2020 | $365.59 Million | -20.09% |
| 2019 | $457.48 Million | -21.30% |
| 2018 | $581.33 Million | -3.00% |
| 2017 | $599.32 Million | +15.75% |
| 2016 | $517.79 Million | -1.16% |
| 2015 | $523.85 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Phibro Animal Health Corporation was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $820.58 Million USD |
| MoneyControl | $820.58 Million USD |
| MarketWatch | $820.58 Million USD |
| marketcap.company | $820.58 Million USD |
| Reuters | $820.58 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Phibro Animal Health Corporation
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including po… Read more